<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Décousus, Hervé</style></author><author><style face="normal" font="default" size="100%">Coutinho, Jonathan M.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Current Treatment of Superficial Vein Thrombosis and Cerebral Venous Thrombosis</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-08-10 10:58:07</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">14-16</style></pages><abstract><style  face="normal" font="default" size="100%">Thrombosis in the small veins is not trivial and requires treatment. Fondaparinux in superficial vein thrombosis of the legs decreases the risk of recurrence, deep vein thrombosis, and pulmonary embolism. Treatment of cerebral vein thrombosis with low molecular weight heparin initially, followed by oral anticoagulation, reduces the risk of death and dependency.</style></abstract><number><style face="normal" font="default" size="100%">21</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>